In last trading session, Virpax Pharmaceuticals Inc (NASDAQ:VRPX) saw 1.24 million shares changing hands with its beta currently measuring 1.41. Company’s recent per share price level of $1.22 trading at -$0.06 or -4.69% at ring of the bell on the day assigns it a market valuation of $1.52M. That closing price of VRPX’s stock is at a discount of -8587.7% from its 52-week high price of $105.99 and is indicating a premium of 11.48% from its 52-week low price of $1.08. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.55 million shares which gives us an average trading volume of 338.02K if we extend that period to 3-months.
Virpax Pharmaceuticals Inc (NASDAQ:VRPX) trade information
Upright in the red during last session for losing -4.69%, in the last five days VRPX remained trading in the red while hitting it’s week-highest on Wednesday, 04/02/25 when the stock touched $1.22 price level, adding 31.38% to its value on the day. Virpax Pharmaceuticals Inc’s shares saw a change of -87.15% in year-to-date performance and have moved -21.29% in past 5-day. Virpax Pharmaceuticals Inc (NASDAQ:VRPX) showed a performance of -74.32% in past 30-days. Number of shares sold short was 23082.0 shares which calculate 0.04 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 3 to the stock, which implies a rise of 59.33% to its current value. Analysts have been projecting 3 as a low price target for the stock while placing it at a high target of 3. It follows that stock’s current price would drop -145.9% in reaching the projected high whereas dropping to the targeted low would mean a loss of -145.9% for stock’s current value.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 14.86% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 78.17% while estimates for its earnings growth in next 5 years are of 42.85%.
Virpax Pharmaceuticals Inc (NASDAQ:VRPX)’s Major holders
Insiders are in possession of 0.96% of company’s total shares while institution are holding 0.40 percent of that, with stock having share float percentage of 0.41%. Investors also watch the number of corporate investors in a company very closely, which is 0.40% institutions for Virpax Pharmaceuticals Inc that are currently holding shares of the company. PARALLEL ADVISORS, LLC is the top institutional holder at VRPX for having 1.0 shares of worth $1.0. And as of 2024-06-30, it was holding 0.0001 of the company’s outstanding shares.
